共 50 条
- [1] Phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer (SCLC)JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)Han, J.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Ctr Lung Canc, Goyang, South KoreaLim, K. Y.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Ctr Lung Canc, Goyang, South KoreaKim, H. Y.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Ctr Lung Canc, Goyang, South KoreaHan, J. H.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Ctr Lung Canc, Goyang, South KoreaOh, S. H.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Ctr Lung Canc, Goyang, South KoreaYun, T.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Ctr Lung Canc, Goyang, South KoreaKim, H. T.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Ctr Lung Canc, Goyang, South KoreaLee, J. S.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Ctr Lung Canc, Goyang, South Korea
- [2] Phase II Study of Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer (SCLC)JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S507 - S507Pietanza, M. C.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USASima, C. S.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAPolley, M. R.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USASumner, D. K.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USATravis, V.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAHeguy, A.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAGinsberg, M. S.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAHolodny, A.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAKris, M. G.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAKrug, L. M.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
- [3] Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapyCANCER, 2020, 126 (17) : 4002 - 4012Park, Sehhoon论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, 81 Irwon Ro, Seoul 06351, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, 81 Irwon Ro, Seoul 06351, South KoreaShim, Joonho论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea Sungkyunkwan Univ, Samsung Med Ctr, Samsung Genome Inst, Sch Med, Seoul, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, 81 Irwon Ro, Seoul 06351, South KoreaMortimer, Peter G. S.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, R&D Oncol, Early Oncol Clin, Cambridge, England Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, 81 Irwon Ro, Seoul 06351, South KoreaSmith, Simon A.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, R&D Oncol, Early Oncol Clin, Boston, MA USA Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, 81 Irwon Ro, Seoul 06351, South KoreaGodin, Robert E.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, R&D Oncol, Early Oncol Clin, Cambridge, England Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, 81 Irwon Ro, Seoul 06351, South KoreaHollingsworth, Simon J.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Oncol Business Unit, Cambridge, England Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, 81 Irwon Ro, Seoul 06351, South KoreaKim, Hee-Jung论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, R&D Oncol, External R&D, Seoul, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, 81 Irwon Ro, Seoul 06351, South KoreaJung, Hyun Ae论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, 81 Irwon Ro, Seoul 06351, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, 81 Irwon Ro, Seoul 06351, South KoreaSun, Jong-Mu论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, 81 Irwon Ro, Seoul 06351, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, 81 Irwon Ro, Seoul 06351, South KoreaPark, Woong-Yang论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea Sungkyunkwan Univ, Samsung Med Ctr, Samsung Genome Inst, Sch Med, Seoul, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, 81 Irwon Ro, Seoul 06351, South KoreaAhn, Jai Sang论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, 81 Irwon Ro, Seoul 06351, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, 81 Irwon Ro, Seoul 06351, South KoreaAhn, Myung-Ju论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, 81 Irwon Ro, Seoul 06351, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, 81 Irwon Ro, Seoul 06351, South Korea论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:
- [4] A phase II trial of pazopanib in relapsed/refractory small cell lung cancer (SCLC).JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)Gandhi, Leena论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAHeist, Rebecca Suk论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USALucca, Joan Vern论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USATemel, Jennifer S.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAFidias, Panos论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAMorse, Linda K.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USAJohnson, Bruce E.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA
- [5] Phase II study of amrubicin and carboplatin in patients with the refractory or relapsed small cell lung cancer (SCLC).JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)Hirose, T.论文数: 0 引用数: 0 h-index: 0机构: Showa Univ, Sch Med, Tokyo 142, Japan Showa Univ, Sch Med, Tokyo 142, JapanShirai, T.论文数: 0 引用数: 0 h-index: 0机构: Showa Univ, Sch Med, Tokyo 142, Japan Showa Univ, Sch Med, Tokyo 142, JapanKusumoto, S.论文数: 0 引用数: 0 h-index: 0机构: Showa Univ, Sch Med, Tokyo 142, Japan Showa Univ, Sch Med, Tokyo 142, JapanSugiyama, T.论文数: 0 引用数: 0 h-index: 0机构: Showa Univ, Sch Med, Tokyo 142, Japan Showa Univ, Sch Med, Tokyo 142, JapanYamaoka, T.论文数: 0 引用数: 0 h-index: 0机构: Showa Univ, Sch Med, Tokyo 142, Japan Showa Univ, Sch Med, Tokyo 142, JapanOkuda, K.论文数: 0 引用数: 0 h-index: 0机构: Showa Univ, Sch Med, Tokyo 142, Japan Showa Univ, Sch Med, Tokyo 142, JapanOhmori, T.论文数: 0 引用数: 0 h-index: 0机构: Showa Univ, Sch Med, Tokyo 142, Japan Showa Univ, Sch Med, Tokyo 142, JapanOhnishi, T.论文数: 0 引用数: 0 h-index: 0机构: Showa Univ, Sch Med, Tokyo 142, Japan Showa Univ, Sch Med, Tokyo 142, JapanAdachi, M.论文数: 0 引用数: 0 h-index: 0机构: Showa Univ, Sch Med, Tokyo 142, Japan Showa Univ, Sch Med, Tokyo 142, Japan
- [6] A phase II study of second-line bendamustine in relapsed or refractory small cell lung cancer (SCLC)JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)Lovly, Christine Marie论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Ingram Canc Ctr, Nashville, TN USALi, Chung-I论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Ingram Canc Ctr, Nashville, TN USAHutchison, Anne Smith论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Ingram Canc Ctr, Nashville, TN USACarbone, David Paul论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Ingram Canc Ctr, Nashville, TN USAJohnson, David H.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Ingram Canc Ctr, Nashville, TN USAKeedy, Vicki Leigh论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Ingram Canc Ctr, Nashville, TN USAPao, William论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Ingram Canc Ctr, Nashville, TN USASandler, Alan论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Ingram Canc Ctr, Nashville, TN USAHorn, Leora论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Ingram Canc Ctr, Nashville, TN USA
- [7] A phase II study of second-line bendamustine in relapsed or refractory small cell lung cancer (SCLC)JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)Venepalli, N. K.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Sch Med, Nashville, TN 37212 USAHutchison, A. S.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Sch Med, Nashville, TN 37212 USACarbone, D. P.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Sch Med, Nashville, TN 37212 USAJohnson, D. H.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Sch Med, Nashville, TN 37212 USAKeedy, V. L.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Sch Med, Nashville, TN 37212 USAPao, W.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Sch Med, Nashville, TN 37212 USASandler, A.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Sch Med, Nashville, TN 37212 USAHorn, L.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
- [8] Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancerCANCER, 2024, 130 (04) : 541 - 552Park, Sehhoon论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South KoreaKim, Yu Jung论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Coll Med, Dept Internal Med, Div Hematol & Med Oncol,Bundang Hosp, Seongnam, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South KoreaMin, Young Joo论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Dept Hematol & Oncol, Ulsan Univ Hosp, Ulsan, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South KoreaMortimer, Peter G. S.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, R&D Oncol, Cambridge, England Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South KoreaKim, Hee-Jung论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, R&D Oncol, External R&D, Seoul, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South KoreaSmith, Simon A.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, R&D Oncol, Cambridge, England Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South KoreaDean, Emma论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, R&D Oncol, Cambridge, England Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South KoreaJung, Hyun Ae论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South KoreaSun, Jong-Mu论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South KoreaPark, Woong-Yang论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Genome Inst, Samsung Med Ctr, Seoul, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South KoreaAhn, Jin Seok论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South KoreaAhn, Myung-Ju论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:
- [9] Final Results of a Phase II Biomarker-Driven Study of Ruxolitinib in Relapsed and Refractory T-Cell LymphomaBLOOD, 2019, 134Moskowitz, Alison J.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAGhione, Paola论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAJacobsen, Eric D.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USARuan, Jia论文数: 0 引用数: 0 h-index: 0机构: Weill Cornell Med Ctr, New York, NY USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USASchatz, Jonathan H.论文数: 0 引用数: 0 h-index: 0机构: Univ Miami, Dept Hematol, Sylvester Comprehens Canc Ctr, Miami, FL USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USANoor, Sarah论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAMyskowski, Patricia论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAHancock, Helen论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USADavey, Theresa论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAObadi, Obadi论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAOnwasigwe, Carlissa论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAGanesan, Nivetha论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAPomerantz, Lauren论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAJarjies, Christine论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAKumar, Priyadarshini论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USASigler, Allison论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAGeyer, Mark B.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USANoy, Ariela论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAStraus, David J.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAHollmann, Travis论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USADogan, Ahmet论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAGalasso, Natasha论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAInghirami, Giorgio论文数: 0 引用数: 0 h-index: 0机构: Weill Cornell Med Ctr, Dept Pathol, New York, NY USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAWeinstock, David M.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USAHorwitz, Steven M.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA
- [10] Biomarker driven phase II umbrella trial study of AZD1775,AZD2014,AZD2811 monotherapy in relapsed small cell lung cancer.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Park, Sehhoon论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South KoreaShim, Joonho论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South KoreaJung, Hyun Ae论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South KoreaSun, Jong-Mu论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South KoreaLee, Se-Hoon论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South KoreaPark, Woong-Yang论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South KoreaAhn, Jin Seok论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South KoreaAhn, Myung-Ju论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South KoreaPark, Keunchil论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea